Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Blog September 13, 2019
States Continue to Explore a Public-Option Plan to Offer Affordable Healthcare
Pharmaceutical innovation in the APAC region Pharmaceutical innovation in the APAC region
Blog September 5, 2019
Pharmaceutical innovation in the APAC region
Regulatory reform in China enhancing clinical trials review and approval Regulatory reform in China enhancing clinical trials review and approval
Blog August 29, 2019
Regulatory reform in China enhancing clinical trials review and approval
Blog August 14, 2019
A Look at PBM Drug Spending: Trend Fueled by Specialty Drug Growth
Blog August 8, 2019
The Evolving Dynamics of Access and Reimbursement in China
Biktarvy, the booming blockbuster, drives HIV market Biktarvy, the booming blockbuster, drives HIV market
Blog July 26, 2019
Biktarvy, the booming blockbuster, drives HIV market
Blog July 22, 2019
Evolution of Health Technology Assessment (HTA) in China
Blog July 2, 2019
The AbbVie-Allergan Acquisition and the Road Ahead
Record new drug approvals: ‘fleeting success’ or here to stay? Record new drug approvals: ‘fleeting success’ or here to stay?
Blog June 27, 2019
Record new drug approvals: ‘fleeting success’ or here to stay?
Blog June 26, 2019
Intermountain Plays Pivotal Role in Optum-DaVita Deal